Royal Bank of Canada’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $154K | Buy |
8,546
+155
| +2% | +$3.11K | ﹤0.01% | 4872 |
|
|
2025
Q4 | $196K | Sell |
8,391
-36,947
| -81% | -$801K | ﹤0.01% | 4777 |
|
|
2025
Q3 | $904K | Sell |
45,338
-48,058
| -51% | -$863K | ﹤0.01% | 4067 |
|
|
2025
Q2 | $1.28M | Buy |
93,396
+90,251
| +2,870% | +$866K | ﹤0.01% | 3682 |
|
|
2025
Q1 | $35K | Sell |
3,145
-600
| -16% | -$6.4K | ﹤0.01% | 5709 |
|
|
2024
Q4 | $40K | Sell |
3,745
-2,379
| -39% | -$28.5K | ﹤0.01% | 5800 |
|
|
2024
Q3 | $79K | Buy |
6,124
+863
| +16% | +$12.8K | ﹤0.01% | 5491 |
|
|
2024
Q2 | $88K | Sell |
5,261
-6,364
| -55% | -$90.5K | ﹤0.01% | 5346 |
|
|
2024
Q1 | $174K | Sell |
11,625
-8,998
| -44% | -$147K | ﹤0.01% | 4809 |
|
|
2023
Q4 | $309K | Buy |
20,623
+3,607
| +21% | +$46.8K | ﹤0.01% | 4707 |
|
|
2023
Q3 | $239K | Buy |
17,016
+764
| +5% | +$12.3K | ﹤0.01% | 4639 |
|
|
2023
Q2 | $168K | Buy |
16,252
+426
| +3% | +$4.7K | ﹤0.01% | 4913 |
|
|
2023
Q1 | $147K | Buy |
15,826
+939
| +6% | +$8.64K | ﹤0.01% | 4873 |
|
|
2022
Q4 | $132K | Buy |
14,887
+5
| +0% | +$47 | ﹤0.01% | 5248 |
|
|
2022
Q3 | $124K | Hold |
14,882
| – | – | ﹤0.01% | 5171 |
|
|
2022
Q2 | $122K | Sell |
14,882
-1,198
| -7% | -$8.23K | ﹤0.01% | 5200 |
|
|
2022
Q1 | $139K | Sell |
16,080
-1,646
| -9% | -$12.8K | ﹤0.01% | 5401 |
|
|
2021
Q4 | $168K | Sell |
17,726
-1,000
| -5% | -$14.1K | ﹤0.01% | 5508 |
|
|
2021
Q3 | $315K | Buy |
18,726
+298
| +2% | +$4.72K | ﹤0.01% | 4738 |
|
|
2021
Q2 | $281K | Sell |
18,428
-84,787
| -82% | -$1.53M | ﹤0.01% | 4775 |
|
|
2021
Q1 | $2.01M | Buy |
103,215
+6,311
| +7% | +$134K | ﹤0.01% | 3001 |
|
|
2020
Q4 | $1.75M | Sell |
96,904
-5,215
| -5% | -$109K | ﹤0.01% | 3043 |
|
|
2020
Q3 | $1.97M | Sell |
102,119
-78
| -0.1% | -$1.77K | ﹤0.01% | 2700 |
|
|
2020
Q2 | $2.67M | Buy |
102,197
+1,384
| +1% | +$33.8K | ﹤0.01% | 2398 |
|
|
2020
Q1 | $1.8M | Sell |
100,813
-1,330
| -1% | -$35.9K | ﹤0.01% | 2565 |
|
|
2019
Q4 | $3.41M | Buy |
102,143
+82,532
| +421% | +$2.25M | ﹤0.01% | 2434 |
|
|
2019
Q3 | $467K | Buy |
19,611
+1,672
| +9% | +$54.7K | ﹤0.01% | 3886 |
|
|
2019
Q2 | $645K | Buy |
17,939
+5,881
| +49% | +$217K | ﹤0.01% | 3682 |
|
|
2019
Q1 | $444K | Buy |
12,058
+5,495
| +84% | +$230K | ﹤0.01% | 3810 |
|
|
2018
Q4 | $283K | Sell |
6,563
-920
| -12% | -$41.4K | ﹤0.01% | 4123 |
|
|
2018
Q3 | $354K | Buy |
7,483
+1,427
| +24% | +$66.3K | ﹤0.01% | 4120 |
|
|
2018
Q2 | $301K | Buy |
6,056
+1,004
| +20% | +$58.4K | ﹤0.01% | 4165 |
|
|
2018
Q1 | $251K | Buy |
5,052
+1,297
| +35% | +$65K | ﹤0.01% | 4185 |
|
|
2017
Q4 | $140K | Buy |
3,755
+2,005
| +115% | +$71.4K | ﹤0.01% | 4623 |
|
|
2017
Q3 | $55K | Buy |
+1,750
| New | +$38.6K | ﹤0.01% | 5361 |
|
Other funds holding URGN
RI
KCM
JFG
PBA
ACA
